The 20 Best COVID-19 Doctors Near Me in Nottingham, MD

Dr. Werbel is a physician-scientist who provides consultative care for patients at Johns Hopkins who experience infectious disease complications before and after organ transplant, as well as in the setting of solid tumors or blood cancers. His research with the Johns Hopkins Transplant Research Center uses a combination of epidemiological and laboratory methods to better personalize the prevention of infectious complications among patients with complex immunodeficiencies. This includes using national cohort studies and clinical trials to optimize the use of vaccines and other prophylactic therapies for high-risk immunosuppressed populations. Dr. Werbel is rated as a Distinguished provider by MediFind in the treatment of COVID-19. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses COVID-19, Severe Acute Respiratory Syndrome (SARS), HIV/AIDS, and Hepatitis. Dr. Werbel is board certified in American Board Of Internal Medicine.

Daniel Brodie is an Intensive Care Medicine specialist and a Pulmonary Medicine provider practicing medicine in Baltimore, Maryland. Dr. Brodie is rated as a Distinguished provider by MediFind in the treatment of COVID-19. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Acute Respiratory Distress Syndrome (ARDS), COVID-19, Respiratory Acidosis, Embolectomy, and Lung Transplant. Dr. Brodie is board certified in American Board Of Internal Medicine.

Dr. Hager is a specialist in Critical Care Medicine. He is an expert in the diagnosis and management of all forms of acute respiratory failure, including asthma, pneumonia, C.O.P.D., neuromuscular diseases, and the acute respiratory distress syndrome. He also has extensive experience in the management of other life-threatening conditions such as pulmonary embolism, gastrointestinal hemorrhage, shock from sepsis, hypovolemia, and heart disease, and metabolic emergencies such as diabetic ketoacidosis and hyperosmolar states. Dr. Hager is rated as a Distinguished provider by MediFind in the treatment of COVID-19. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Severe Acute Respiratory Syndrome (SARS), COVID-19, Cerebral Hypoxia, and Acute Respiratory Distress Syndrome (ARDS). Dr. Hager is board certified in American Board Of Internal Medicine.

Sriram Padmanabhan is a Nuclear Medicine provider practicing medicine in Baltimore, Maryland. Dr. Padmanabhan is rated as an Experienced provider by MediFind in the treatment of COVID-19. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Coronary Heart Disease, Atrial Fibrillation, Atherosclerosis, and Angina.

Stuart Willes is an Intensive Care Medicine provider practicing medicine in Baltimore, Maryland. Dr. Willes is rated as an Experienced provider by MediFind in the treatment of COVID-19. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Pneumonia, Cerebral Hypoxia, Lung Metastases, Gastrostomy, and Liver Embolization.

Mary Richert is an Intensive Care Medicine provider practicing medicine in Baltimore, Maryland. Dr. Richert is rated as an Experienced provider by MediFind in the treatment of COVID-19. Her clinical expertise encompasses COVID-19 and Pneumonia. Dr. Richert is board certified in American Board Of Internal Medicine.

Jeffrey Brown is a Cardiologist practicing medicine in Baltimore,, Maryland. Dr. Brown is rated as an Experienced provider by MediFind in the treatment of COVID-19. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Cardiomyopathy, Atherosclerosis, Coronary Heart Disease, and Atrial Fibrillation.

Bhavin Patel is a Cardiologist practicing medicine in Baltimore,, Maryland. He has been practicing medicine for over 18 years. Dr. Patel is rated as an Experienced provider by MediFind in the treatment of COVID-19. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Heart Attack, Apoplexy, Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Rahul Anand is a Cardiologist practicing medicine in Baltimore,, Maryland. Dr. Anand is rated as an Experienced provider by MediFind in the treatment of COVID-19. His clinical expertise encompasses Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy, Thromboangiitis Obliterans, Familial Neurocardiogenic Syncope, and Coronary Heart Disease.

Tamara Ashvetiya is a Cardiologist practicing medicine in Baltimore,, Maryland. Dr. Ashvetiya is rated as an Experienced provider by MediFind in the treatment of COVID-19. Her clinical expertise encompasses Heart Attack, Apoplexy, Pulmonary Edema, and Heart Failure with Preserved Ejection Fraction (HFpEF).

Ebony Alston is an Internal Medicine provider practicing medicine in Baltimore, Maryland. Dr. Alston is rated as an Experienced provider by MediFind in the treatment of COVID-19. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Heart Attack, Apoplexy, Glucocorticoid-Remediable Aldosteronism, and Hypertension.

Franklin Chatham is a Cardiologist practicing medicine in Baltimore,, Maryland. Dr. Chatham is rated as an Experienced provider by MediFind in the treatment of COVID-19. His clinical expertise encompasses Heart Failure, Pulmonary Edema, Familial Neurocardiogenic Syncope, and Atrial Fibrillation.

Mansoor Mozayan is a Cardiologist practicing medicine in Baltimore, Maryland. Dr. Mozayan is rated as an Experienced provider by MediFind in the treatment of COVID-19. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Coronary Heart Disease, Heart Attack, Angina, and Atrial Fibrillation.

Rabin Shrestha is an Intensive Care Medicine provider practicing medicine in Rosedale, Maryland. Dr. Shrestha is rated as an Experienced provider by MediFind in the treatment of COVID-19. His clinical expertise encompasses Sepsis, Pneumonia, Atypical Pneumonia, Hospital-Acquired Pneumonia, and Gastrostomy.

Rama Vunnam is a Cardiologist practicing medicine in Baltimore,, Maryland. Dr. Vunnam is rated as an Experienced provider by MediFind in the treatment of COVID-19. His clinical expertise encompasses Ventricular Fibrillation, Arrhythmias, COVID-19, Ventricular Tachycardia, and Hip Replacement.

Thomas Cudjoe is a primary care provider, practicing in Geriatrics in Baltimore, Maryland. Dr. Cudjoe is rated as an Advanced provider by MediFind in the treatment of COVID-19. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses COVID-19, Severe Acute Respiratory Syndrome (SARS), and Dementia. Dr. Cudjoe is board certified in American Board Of Internal Medicine.

Dr. Galiatsatos is a pulmonary and critical care medicine physician. He is an expert in the diagnosis and treatment of obstructive lung disease, tobacco cessation, and in the care of critically ill patients in the Medical ICU. He is a member of the Obstructive Lung Disease Group at Johns Hopkins, oversees the Tobacco Treatment Clinic and provides teaching to medical students and residents at Johns Hopkins. Dr. Galiatsatos is rated as an Advanced provider by MediFind in the treatment of COVID-19. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Pulmonary Arteriovenous Fistula, Chronic Obstructive Pulmonary Disease (COPD), COVID-19, and Severe Acute Respiratory Syndrome (SARS). Dr. Galiatsatos is board certified in American Board Of Internal Medicine.

Dr. Gregory Kirk is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in oncology and, at the Johns Hopkins Bloomberg School of Public Health, in epidemiology. His areas of clinical expertise include epidemiology, hepatitis, HIV, AIDS and infectious diseases. He serves as the vice chair for clinical and translational research at the Johns Hopkins School of Medicine. Dr. Kirk received his undergraduate degree from Oklahoma State University. He earned a Ph.D. and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He earned his M.D. from the University of Oklahoma Health Sciences Center College of Medicine. He completed a residency in preventative medicine at the Johns Hopkins Bloomberg School of Public Health and in internal medicine at Georgetown University. He performed a fellowship in infectious diseases at the National Institute of Allergy and Infectious Diseases. His research focuses on understanding and preventing the long-term consequences of chronic HIV infection, particularly the malignant complications of HIV and viral hepatitis. He has extensive research and clinical experience in Africa, leading the Gambia Liver Cancer Study, one of the largest studies of hepatocellular carcinoma (HCC) performed in the continent, in addition to years of collaborative research in Uganda. Dr. Kirk pioneered the use of elastography and application of novel aflatoxin-associated biomarkers of HCC risk to be applied in Consortium projects. He has strong, multidisciplinary team leadership skills as principal investigator of the ALIVE cohort and several other collaborative studies in Baltimore. Dr. Kirk is rated as an Advanced provider by MediFind in the treatment of COVID-19. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Hepatitis C, Hepatitis, and COVID-19. Dr. Kirk is board certified in American Board Of Internal Medicine.

Dr. Kelly Gebo is a graduate of The Johns Hopkins University School of Medicine. She also earned an MPH in Epidemiology from The Johns Hopkins Bloomberg School of Public Health. She completed residency training in Internal Medicine at The Johns Hopkins Hospital followed by an infectious diseases fellowship and two additional years of fellowship training as a Robert Wood Johnson Clinical Scholar, also at Hopkins. Her clinical and research interests include clinical outcomes and healthcare utilization research within infectious diseases. She was Director of the JHU Public Health Studies Program between the Krieger School for Arts and Sciences and the Bloomberg School for Public Health, was an American Council of Education Fellow (hosted at the University of Pennsylvania) and was the inaugural Vice Provost for Education at Johns Hopkins. She was on sabbatical at Stanford University School of Medicine 2019-20 and served as the Chief Medical and Scientific Officer for the All of Us Research Program 2018-2020. She currently serves as the director of the Johns Hopkins Clinical Research Scholars Program and is Deputy Director of the Johns Hopkins Institute for Clinical and Translational Research. She has mentored undergraduate, public health and medical students, trainees, and junior faculty on infectious diseases and health services projects. She has authored or co-authored numerous chapters and over 250 papers. She is a member of the American Society of Clinical Investigation and has been awarded the David Levine Prize for mentoring at Johns Hopkins. LinkedIn https://www.linkedin.com/in/kelly-gebo-13377811/. Dr. Gebo is rated as an Advanced provider by MediFind in the treatment of COVID-19. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex. Dr. Gebo is board certified in American Board Of Internal Medicine.

Dr. Yukari Manabe is a Professor in the Division of Infectious Diseases in the Department of Medicine with secondary appointments in the Bloomberg School of Public Health Department of International Health and the Department of Microbiology and Molecular Immunology. Dr. Manabe began her career working on the basic science aspects of tuberculosis (TB) immunopathogenesis in comparative animal models of infection, particularly latency, reactivation, and immune reconstitution inflammatory syndrome (IRIS) in the rabbit model within the Johns Hopkins Center for Tuberculosis Research. In 2007, she was seconded to the Infectious Diseases Institute (IDI) at Makerere College of Health Sciences as the Associate Medical Laboratory Director of the College of American Pathologists certified Makerere University-Johns Hopkins University Clinical Core Lab to study antiretroviral associated TB and IRIS. She then became the Head of Research at the IDI in 2008 until 2012 where she built research capacity and infrastructure to train Ugandan investigators. Since returning to Hopkins, she has become the PI of the Johns Hopkins POC STD Center (U54 funded through NIH) which is part of the newly formed Johns Hopkins Center for Innovative Diagnostics for Infectious Diseases. The Center develops new diagnostics, funds development for point-of-care diagnostics, evaluates (validation and verification) new technology, and performs pre-clinical studies to accelerate the development of infectious disease assays (STIs, TB, acute febrile illness, HIV, syphilis, viral hepatitis). Dr. Manabe is particularly interested in rapid, point-of-care infectious disease diagnostics suitable for the resource-limited settings particularly in sub-Saharan Africa (SSA). Her research has focused on accuracy testing of various rapid, point-of-care diagnostics for HIV and related infectious diseases of clinical importance in SSA. Studies have ranged from evaluations of performance accuracy through clinical implementation science studies on the patient-centered outcomes and impactful use of new rapid diagnostics. Dr. Manabe obtained her undergraduate degree from Yale University and her M.D. from Columbia University College of Physicians and Surgeons. After completing both her residency in Internal Medicine and fellowship in Infectious Diseases at Johns Hopkins Hospital, she joined the faculty in 1999. Dr. Manabe is rated as an Advanced provider by MediFind in the treatment of COVID-19. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses HIV/AIDS, Gonorrhea, Cryptococcosis, Meningitis, and Tissue Biopsy.